Several Wall Street analysts have come out bullish on cannabis stocks in recent months, but one analyst said Monday that Aurora Cannabis Inc ACB is the clear top choice in the sector.
The Analyst
Cowen analyst Vivien Azer reiterated an Outperform rating on Aurora with a CA$15 ($11.38) price target.
Need more cannabis news? Check out all of our coverage here.
The Thesis
While a number of Canadian cannabis producers are positioned to take advantage of a global boom in demand, Azer said Aurora is the only one of the top growers that is also on track to become profitable in the near-term. (See her track record here.)
Aurora is second to Canopy Growth Corp CGC in terms of size, but the analyst said Canopy’s record CA$98-million loss in the first quarter was telling.
“While a number of peers have communicated a longer pathway to profitability, ACB has the opportunity to be among the few Canadian LPs to reach positive EBITDA as soon as 4Q19 (ending June 30), which is a particular standout as category leader WEED posted an expanded EBITDA loss in calendar 1Q19 (at -C$98 mm)."
Aurora's profitability and margins should get an additional boost from a mix shift toward extracts and novel form factors, Azer said.
Cowen first came out bullish on Aurora in March, telling investors the stock deserves to trade at a premium valuation due to its unique path to profitability.
In the long-term, Azer estimates the Candian adult-use cannabis market will be worth about CA$12 billion by 2025 and the international medicinal cannabis market will be worth $31 billion by 2024.
In the near-term, Azer said investors should expect Aurora to focus on vapor, adding that a major strategic partner could be announced in the next couple of quarters.
Price Action
Aurora shares were up 2.47% at $7.48 at the time of publication Monday.
Related Links:
Analyst: Canopy Growth Still A Top Cannabis Stock Despite Mixed Quarter
Canopy Shareholders Approve Acreage Deal, Legalization In Focus
Photo courtesy of Aurora Cannabis.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.